President Joe Biden is set to sign the Congenital Heart Reauthorization Act Nov. 22, extending and expanding the CDC’s National Congenital Heart Disease Research, Surveillance and Awareness Program.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
